Observational studyPloS one2026

The lived experience of adolescents with X-linked hypophosphataemia treated with burosumab at end of skeletal growth: a mixed-methods analysis.

Vrinda Saraff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.